BMN 673 manufacturers and suppliers

BMN 673 suppliers

BMN 673

CAS:: 1207456-01-6

MF:: C19H14F2N6O

MW:: 380.35

Suppliers by country/region

Company Type

Properties

Melting point:: 247 - 249°C

Density: 1.63

storage temp.: Hygroscopic, -20°C Freezer, Under inert atmosphere

solubility: DMSO (Slightly), Methanol (Slightly)

pka: 10.14±0.60(Predicted)

form: Solid

color: White to Off-White

InChI: InChI=1S/C19H14F2N6O/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28/h2-8,15-16,24H,1H3,(H,26,28)/t15-,16-/m1/s1

InChIKey: HWGQMRYQVZSGDQ-HZPDHXFCSA-N

SMILES: C1(=O)C2=C3C(N[C@H](C4=CC=C(F)C=C4)[C@@H](C4N(C)N=CN=4)C3=NN1)=CC(F)=C2

Safety Information

Symbol(GHS): GHS08

Signal word: Danger

Hazard statements: H360-H372-H341

Precautionary statements: P260-P264-P270-P314-P501-P201-P202-P281-P308+P313-P405-P501

Use

BMN-673 selectively binds to PARP and prevents PARP-mediated DNA repair of single strand DNA breaks via the base-excision repair pathway. This enhances the accumulation of DNA strand breaks, promotes genomic instability and eventually leads to apoptosis. BMN 673 selectively kills cancer cells with BRCA-1 or BRCA-2 mutations. BMN 673 demonstrates single-agent cytotoxicityin BRCA-1 mutant (MX-1, IC50 = 0.3 nM) and BRCA-2 mutant cells (Capan-1, IC50 = 5 nM). In contrast, in MRC-5 normal human fibroblastand other tumor cell lines with wild-type BRCA-1 and BRCA-2 genes, IC50 of BMN 673 ranges between 90 nM and 1.9 μM. In cultured human cancer cells, BMN 673 also significantly enhances the cytotoxic efficacy of both Temozolomide and SN-38. Off-target molecular screening did not identify significant non-specific activity for this class of PARP inhibitors.

You can find BMN 673 suppliers, manufacturers, and distributors from countries such as China, United States and the The Netherlands here. Browse to the tetrahydrofuran product information displayed by the supplier, as well as the supplier's contact and capability information.